Akiyama Takuya, Gibson Matthew C
Department of Biology, Indiana State University, Terre Haute, IN 47809, USA.
The Porter Cancer Research Center, Indiana State University, Terre Haute, IN 47809, USA.
bioRxiv. 2025 May 10:2025.05.08.652841. doi: 10.1101/2025.05.08.652841.
Somatic mutations of , encoding a small GTPase, are detected in a wide range of human cancers. Tumor genome sequencing further reveals a cancer type-dependent mutational spectrum for the gene, suggesting that tissue- and allele-specific effects underlie tumorigenic activity. Although biochemical studies have characterized the GTPase activity of several Ras variants , precisely how somatic mutations of the endogenous locus differentially affect tissue growth and homeostasis remain elusive. Here we engineered the endogenous locus to create a spectrum of inducible oncogenic alleles and then compared their activities . In the developing wing primordium, somatic clones carrying the oncogenic mutation exhibited a weak activation of downstream MAPK signaling but did not disrupt tissue architecture. However, cell clones carrying the same allele in the adult midgut exhibited a growth advantage and progressively took over the tissue, resulting in intestinal barrier dysfunction. In contrast, cell clones expressing a distinct allele, , formed aberrant cysts that disrupted epithelial architecture and triggered local cell death. Conversely, when we induced cell clones carrying in the midgut, hyper-proliferating mutant cells rapidly expanded to occupy the entire tissue. Surprisingly, this population of rapidly expanding mutant cells was eventually eliminated from the midgut, restoring cells and normal barrier function. Thus, in the midgut, was ultimately more deleterious than due to the regression of mutant cells. These results establish a new model for somatic mutagenesis at the locus and illuminate a mechanistic basis for the tissue-specific effects of oncogenic variants. Further, this study provides direct evidence that allele-dependent clonal dynamics may play a critical role in the tissue-selectivity of oncogenic mutations.
编码一种小GTP酶的基因的体细胞突变在多种人类癌症中被检测到。肿瘤基因组测序进一步揭示了该基因的癌症类型依赖性突变谱,表明组织和等位基因特异性效应是肿瘤发生活性的基础。尽管生化研究已经对几种Ras变体的GTP酶活性进行了表征,但内源性基因座的体细胞突变如何差异地影响组织生长和稳态仍不清楚。在这里,我们改造了内源性基因座,以创建一系列可诱导的致癌等位基因,然后比较它们的活性。在发育中的翅原基中,携带致癌突变的体细胞克隆表现出下游MAPK信号的弱激活,但没有破坏组织结构。然而,在成年中肠中携带相同等位基因的细胞克隆表现出生长优势,并逐渐占据组织,导致肠道屏障功能障碍。相比之下,表达不同等位基因的细胞克隆形成异常囊肿,破坏上皮结构并引发局部细胞死亡。相反,当我们在中肠中诱导携带的细胞克隆时,过度增殖的突变细胞迅速扩张以占据整个组织。令人惊讶的是,这一快速扩张的突变细胞群体最终从中肠中被清除,恢复了细胞和正常屏障功能。因此,在中肠中,由于突变细胞的消退,最终比更具危害性。这些结果建立了一个新的基因座体细胞诱变模型,并阐明了致癌变体组织特异性效应的机制基础。此外,这项研究提供了直接证据,表明等位基因依赖性克隆动态可能在致癌突变的组织选择性中起关键作用。